{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4250"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to provide an alternative process for review of\n\t\t\t safety and effectiveness of nonprescription sunscreen active ingredients\n\t\t\t and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140313", "#text": "March 13, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Whitfield", "@name-id": "W000413"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Dingell", "@name-id": "D000355"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H507337563DF34F068FCC6B063FA5ABA8", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"@proposed": "true", "#tail": "\n        ", "@entity-type": "act", "@value": "Sunscreen Innovation Act", "short-title": {"#tail": "\n          ", "#text": "Sunscreen Innovation Act"}, "#text": "\n            "}, "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H3B5EBFE64CEA42358C6EF161DA0B8955"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subchapter A of chapter V", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V/sch:A"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "uscode", "#text": "21 U.S.C. 351 et seq", "@value": "usc/21/351/etseq"}, "@parsable-cite": "usc/21/351", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Regulation of nonprescription sunscreen active ingredients"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "524B."}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Procedures for classifying sunscreen active ingredients"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall review and determine whether nonprescription sunscreen conditions are generally\n\t\t\t recognized as safe and effective and shall ensure that any such conditions\n\t\t\t that are marketed in the United States are appropriately labeled.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "HAE03FADC67FD490A9817D5393ED10876", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means any component that is intended to furnish pharmacological activity or other direct effect in\n\t\t\t the diagnosis, cure, mitigation, treatment, or prevention of disease, or\n\t\t\t to affect the structure or function of the body of humans or animals. The\n\t\t\t term includes components that may undergo chemical change in the\n\t\t\t manufacture of a drug and may be present in a drug in a modified form\n\t\t\t intended to furnish the specified activity or effect.", "#text": "active ingredient"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Active ingredient"}, "#text": "\n              ", "@id": "H5650E08733504B19B828121BE9F9A208"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means an active ingredient that absorbs, reflects, or scatters radiation in the ultraviolet range\n\t\t\t at wavelengths from 290 to 400 nanometers.", "#text": "sunscreen active ingredient"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Sunscreen active ingredient"}, "#text": "\n              ", "@id": "H143CD09906C540909EFA6746DDCDBE10"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "term": {"#tail": " means a sunscreen active ingredient (or a combination of sunscreen active ingredients), dosage\n\t\t\t form, dosage strength, or route of administration, marketed for a specific\n\t\t\t nonprescription use.", "#text": "sunscreen condition"}, "#text": "The term "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Sunscreen condition"}, "#text": "\n              ", "@id": "HF4E515D7FE0C41EEBB7A6C487F1C0503"}], "#text": "\n            ", "@id": "HD55792882FA84D4D8D531A61BE454A16"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "To be eligible for review under this section, a sunscreen condition shall\u2014"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Criteria for eligibility"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "not be included in the stayed sunscreen monograph; and"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "HC65459CCDEE9495A814C02C2E4E85D31", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "have been marketed as a nonprescription sunscreen condition in the United States or at least 1\n\t\t\t other country, or marketed as a cosmetic or dietary supplement in 1 or\n\t\t\t more counties other than the United States\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "HC5697CD824C54E99924E9F6218594B44", "@commented": "no", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "for a minimum of 5 continuous years; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "H9C4501113F684C6991AC55628B012D26", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " based upon the information submitted under\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " and ", "@entity-type": "act", "#text": "subparagraphs (D)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:1/sp:D", "@proposed": "true"}, {"#tail": " and, if applicable,\n\t\t\t ", "@entity-type": "act", "#text": "(E) of subsection (d)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:1/sp:E", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)(2)(A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:A/cl:ii", "@proposed": "true"}], "#text": "in sufficient quantity, as determined by the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "HD3EB7F67892047BDA483690ED44D8790", "@commented": "no"}]}], "#text": "\n            ", "@id": "H6B8A3286662342E1B680074CC5D2B634", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Application for eligibility"}, "paragraph": [{"#tail": "\n            ", "@id": "H21B8ED4380DF459ABE39C065D34D5097", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " desiring to market\n\t\t\t such condition in the United States may submit an application to the\n\t\t\t ", "@entity-type": "act", "#text": "subsection (c)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:c", "@proposed": "true"}, {"#tail": ", in such manner and containing such information as required by\n\t\t\t the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", including the following:", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A sponsor of a nonprescription sunscreen condition described in "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Basic information about the sunscreen condition (including a description of each active ingredient,\n\t\t\t pharmacologic class, intended nonprescription use, nonprescription\n\t\t\t strength and dosage form, route of administration, and directions for\n\t\t\t use)."}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H6DD1F929A7AA4BD0AFAF1C47B122F913", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A detailed chemical description of the sunscreen active ingredient that includes a full description\n\t\t\t of the drug substance, including its physical and chemical\n\t\t\t characteristics, the method of synthesis (or isolation) and purification\n\t\t\t of the drug substance, and any specifications and analytical methods\n\t\t\t necessary to ensure the identity, strength, quality, and purity of the\n\t\t\t drug substance, including reference to the current edition of the official\n\t\t\t National Formulary, the United States Pharmacopeia, or foreign\n\t\t\t compendiums, where applicable."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H6C92A242A4B04617BE2C996F4990F7D4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A list of each country in which the sunscreen condition has been marketed."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H43442DC6DFB84A7EB5ECC943924B92B8", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The cumulative total number of dosage units sold for each dosage form of the sunscreen condition,\n\t\t\t including total weight of the active ingredient, package size for each\n\t\t\t dosage form in which the condition is marketed as nonprescription, and an\n\t\t\t estimate of the minimum number of potential consumer exposures to the\n\t\t\t condition."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H5E854F8A7FE34009959182A23526B153", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The use pattern (according to the label) for each country in which the sunscreen condition is\n\t\t\t marketed and any changes in use pattern that have occurred over time."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H6E424D36366C494691D373A77A96CC5A", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A list of all countries in which the sunscreen condition has been withdrawn from marketing or in\n\t\t\t which an application for nonprescription marketing approval has been\n\t\t\t denied and an explanation for such withdrawal or application denial."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "H220F4FB166264AB2A2A7DFB3253813D5", "#text": "\n                "}]}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " may require supplemental information.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The manner in which the sunscreen condition has been marketed to consumers. If the sunscreen\n\t\t\t condition is marketed to consumers as a nonprescription pharmacy only\n\t\t\t condition, the "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H5B091AAACF2C46AF855E203FFCB8CF4A", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A description of the population demographics and the source from which this information has been\n\t\t\t compiled, to ensure that the sunscreen condition's use can be reasonably\n\t\t\t extrapolated to the population of the United States."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "#text": "\n                  ", "@id": "HE51F08F71B3F4F2785BB14B7739EDDD3", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A description of the country\u2019s system for identifying adverse drug experiences, especially those\n\t\t\t found in nonprescription marketing experience, including method of\n\t\t\t collection if applicable."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HD9B718C8506948368A804F68A29546D6", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A statement of how long the sunscreen condition has been marketed in each country and how long the\n\t\t\t current product labeling has been in use, accompanied by a copy of the\n\t\t\t current product labeling, including a translation into English of any\n\t\t\t labeling that is not in English, and a statement of whether the current\n\t\t\t product labeling has been authorized, accepted, or approved by a\n\t\t\t regulatory body in each country where the condition is marketed."}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "HA986A0935A1340DAAAD75428A7D40113", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A list of all countries where the sunscreen condition is marketed as a prescription drug only and\n\t\t\t an explanation for such restriction."}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "H4D196654AFBE4633B16EFF859E800970", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the sponsor shall submit the\n\t\t\t following information for each country in which the sunscreen condition\n\t\t\t has been marketed:", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:1", "@proposed": "true"}, "#text": "In the case of an application with respect to a nonprescription sunscreen condition that has not\n\t\t\t been marketed in the United States for 5 continuous years, in addition to\n\t\t\t the information required under "}, "#text": "\n                ", "@id": "H65E0BDB028A94D579A37D111E4792316", "@commented": "no"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " with respect\n\t\t\t to only 5 such countries, including\u2014", "@entity-type": "act", "#text": "clauses (i) through (iv) of subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:A/cl:i..iv", "@proposed": "true"}, "#text": "may submit information in accordance with "}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "item": [{"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the country with a minimum of 5 continuous years of nonprescription marketing;"}, "enum": {"#tail": "\n                      ", "#text": "(aa)"}, "@id": "H9E696842C1A1485E830205F50DA1CDCC", "#text": "\n                      "}, {"#tail": "\n                    ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the country with the longest duration of marketing; and"}, "enum": {"#tail": "\n                      ", "#text": "(bb)"}, "@id": "H3A5F160763DA43D8B746A0A16C712BBA", "#text": "\n                      "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t\t", "#text": "the country with the most support for marketing, such as a large volume of sales with cultural\n\t\t\t diversity among users of the product; and"}, "enum": {"#tail": "\n                      ", "#text": "(cc)"}, "@id": "H6FB9BE6D5283434EB138349510BEEDD1", "#text": "\n                      "}], "#text": "\n                    ", "@id": "HE43CC9AED3E84D80A69F007EA8772CFD"}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:B/cl:i/scl:I", "@proposed": "true"}, "#text": "shall explain the basis for the countries selected under "}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H03AE723AB3424DDDB9F69D5CAE42300F", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "shall provide information from more than 5 countries if such information is needed to support the\n\t\t\t application."}, "enum": {"#tail": "\n                    ", "#text": "(III)"}, "@id": "HBA247F04534C4C95AE3CAA7C1A40B0EB", "#text": "\n                    "}], "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n                  ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In the case of a sunscreen condition that has been marketed as a nonprescription sunscreen in more\n\t\t\t than 5 countries, with a minimum of 5 continuous years of marketing in at\n\t\t\t least one such country, the sponsor\u2014"}, "#text": "\n                  ", "@id": "H89C77381EF8D49679DA48CD4C7EA7CE8"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " in 1\n\t\t\t or more countries listed in ", "@entity-type": "act", "#text": "items (aa) through (cc) of clause (i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:B/cl:i/scl:I/i:aa..cc", "@proposed": "true"}, {"#tail": ", at least 1 such country\n\t\t\t shall be included among the 5 countries selected under such ", "@entity-type": "act", "#text": "section 802(b)(1)(A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:802/ss:b/p:1/sp:A"}, {"#tail": ".", "@entity-type": "act", "#text": "clause (i)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d/p:2/sp:B/cl:i/scl:I", "@proposed": "true"}], "#text": "If the sunscreen condition meets the criteria under "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n                  ", "#text": "Requirement"}, "#text": "\n                  ", "@id": "H9F54EFC2601540E79B1387884DA4BE0B"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Sunscreen conditions that have been marketed in more than 5 countries"}, "#text": "\n                ", "@id": "HE725A2BA1B0B49889004FFA07968FA50"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Sunscreen conditions that have not been marketed in the United States for 5 continuous years"}, "#text": "\n              ", "@id": "HC96A2C2DD9404A438CD34423C13FF254", "@commented": "no"}, {"#tail": "\n          ", "text": {"short-title": {"#tail": ". Applications for such sunscreen conditions shall be considered in accordance with ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}, "#tail": "\n\t\t\t\t\t\t", "#text": "The requirements of this subsection shall not apply to a sunscreen condition deemed eligible for\n\t\t\t review of safety and effectiveness by publication of a notice of\n\t\t\t eligibility in the Federal Register prior to the date of enactment of the "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Pending applications"}, "#text": "\n              ", "@id": "HD54B2DD758CF4D4083D10E7815DDA146", "@commented": "no"}], "#text": "\n            ", "@id": "H464C124CB7CE4C87BD2AC3A8EF6380F3"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d", "@proposed": "true"}, {"#tail": " shall make the application\n\t\t\t publicly available, with redactions for confidential commercial\n\t\t\t information or trade secret information, and any other information exempt\n\t\t\t from disclosure pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ",\n\t\t\t ", "@entity-type": "uscode", "#text": "\n                ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1905", "#text": "section 1905", "@legal-doc": "usc"}, "@value": "usc/18/1905"}, {"#tail": ", or ", "@entity-type": "uscode", "#text": "\n                ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/552", "#text": "section 552(b)", "@legal-doc": "usc"}, "@value": "usc/5/552/b"}, {"#tail": ". Applications shall remain confidential during the ", "@entity-type": "act", "#text": "section 301(j) of this\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:j"}, {"#tail": "\n\t\t\t consideration of eligibility.", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}], "#text": "If a condition is found eligible under "}, "enum": {"#tail": "\n            ", "#text": "(e)"}, "header": {"#tail": "\n            ", "#text": "Public availability"}, "#text": "\n            ", "@id": "H06FC9AC3947A42C3B882511F7C792707", "@commented": "no"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(f)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "New sunscreen condition application"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the\n\t\t\t ", "@entity-type": "act", "#text": "subsection (d)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:d", "@proposed": "true"}, {"#tail": " shall determine if the sunscreen condition is eligible for\n\t\t\t further review for safety and effectiveness. In the case of a sunscreen\n\t\t\t condition determined to be eligible, the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall publish a notice\n\t\t\t of eligibility in the Federal Register, and provide interested persons an\n\t\t\t opportunity to submit published and unpublished data related to the safety\n\t\t\t and effectiveness of the sunscreen condition for its intended\n\t\t\t nonprescription uses, in accordance with ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". In the case of a\n\t\t\t sunscreen condition determined not eligible, the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": " shall issue a\n\t\t\t letter to the sponsor, which shall be made publicly available.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Not later than 60 days after the submission of an eligibility application under "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Eligibility determination"}, "#text": "\n              ", "@id": "HFFF31AE6643642AE8989BDA26976B0B7"}, {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the sponsor and other interested parties shall\n\t\t\t submit safety and effectiveness data to the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:1", "@proposed": "true"}, {"#tail": " for further review,\n\t\t\t as described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2/sp:B", "@proposed": "true"}], "#text": "Within 60 days of the publication in the Federal Register of an application deemed eligible, as\n\t\t\t described in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "#text": "\n                ", "@id": "H88D7C30DAD784745B15B57FB80D2BB7D"}, {"#tail": "\n              ", "clause": [{"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "With respect to individual active components, controlled studies, partially controlled or\n\t\t\t uncontrolled studies, documented case reports, pertinent marketing\n\t\t\t experiences that may influence a determination as to the safety of each\n\t\t\t individual active component, and pertinent medical and scientific\n\t\t\t literature."}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "header": {"#tail": "\n                    ", "#text": "Individual active components"}, "#text": "\n                    ", "@id": "H790F8F1AC0244F7D8CAD58B3F5F78312"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "With respect to combinations of the individual active components, controlled studies,\n\t\t\t partially controlled or uncontrolled studies, documented case reports,\n\t\t\t pertinent marketing experiences that may influence a determination as to\n\t\t\t the safety of combinations of the individual active component, and\n\t\t\t pertinent medical and scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "header": {"#tail": "\n                    ", "#text": "Combinations of individual active components"}, "#text": "\n                    ", "@id": "H7FA37FCD3DA241C193EF418B3CA43414"}], "enum": {"#tail": "\n                  ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Human safety data"}, "#text": "\n                  ", "@id": "H33AD9E096D004B65AF4E021D464BA836"}, {"#tail": "\n                ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "With respect to individual active components, controlled studies, partially controlled or\n\t\t\t uncontrolled studies, documented case reports, pertinent marketing\n\t\t\t experiences that may influence a determination on the efficacy of each\n\t\t\t individual active component, pertinent medical and scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "header": {"#tail": "\n                    ", "#text": "Individual active components"}, "#text": "\n                    ", "@id": "H3C25EA7AC3F8425BBD6CB7BC0D795D3B"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "With respect to combinations of the individual active components, controlled studies,\n\t\t\t partially controlled or uncontrolled studies, documented case reports,\n\t\t\t pertinent marketing experiences that may influence a determination on the\n\t\t\t efficacy of combinations of the individual active components, and\n\t\t\t pertinent medical and scientific literature."}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "header": {"#tail": "\n                    ", "#text": "Combinations of individual active components"}, "#text": "\n                    ", "@id": "H5843979749BA45EBB722EB24E7E90B34"}], "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Efficacy data"}, "#text": "\n                  ", "@id": "HE19FC4DC612F49A1B9B67FBFFA78A43D"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A summary of the data and views setting forth the medical rationale and purpose (or lack thereof)\n\t\t\t for the sunscreen condition and the scientific basis (or lack thereof) for\n\t\t\t the conclusion that the condition has been proven safe and effective for\n\t\t\t the intended use. If there is an absence of controlled studies in the\n\t\t\t material submitted, an explanation as to why such studies are not\n\t\t\t considered necessary must be included."}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "header": {"#tail": "\n                  ", "#text": "Data setting forth medical rationale and purpose"}, "#text": "\n                  ", "@id": "H4F60F67779704A9291EF3AF4809A07D5"}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "An applicable United States Pharmacopoeia or National Formulary for the sunscreen active ingredient\n\t\t\t or a proposed standard for inclusion in an article to be recognized in an\n\t\t\t official drug monograph for the active ingredient, including information\n\t\t\t showing that the official or proposed compendial monograph for the active\n\t\t\t ingredient is consistent with the active ingredient used in the studies\n\t\t\t establishing safety and effectiveness and with the active ingredient\n\t\t\t marketed in the nonprescription product to a material extent and for a\n\t\t\t material time. If differences exist between the official or proposed\n\t\t\t compendial monograph for the active ingredient and the active ingredient\n\t\t\t that is the subject of the application, sponsor shall explain such\n\t\t\t differences."}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "header": {"#tail": "\n                  ", "#text": "Official drug monograph"}, "#text": "\n                  ", "@id": "H58E6EF058A5F40108D17C692C45636A8"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", from each country\n\t\t\t where the condition has been or is currently marketed as a prescription\n\t\t\t drug or as a nonprescription drug or product.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "A list of all serious adverse drug experiences, as defined by the "}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "header": {"#tail": "\n                  ", "#text": "Adverse drug experiences"}, "#text": "\n                  ", "@id": "HA954D9586CBF4F79B08F0788A5974426"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Required submissions regarding data"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Submissions under this paragraph shall include the following:"}, "#text": "\n                ", "@id": "H178623673B4240FC8640CCB4F604E5D3"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",  the  sponsor may submit\n\t\t\t information with\n\t\t\t respect to animal safety data, including controlled studies and partially\n\t\t\t controlled or uncontrolled studies, in the case of an application for\n\t\t\t individual active components, and controlled studies and partially\n\t\t\t controlled or uncontrolled studies in the case of an application for\n\t\t\t combinations of individual active components.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2/sp:B", "@proposed": "true"}, "#text": "In addition to the information required under "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Optional animal safety data"}, "#text": "\n                ", "@id": "H639021AA0AA345BFBE6B83A5E91D0AE6"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall make data and information submitted by the sponsor, or pursuant to a notice\n\t\t\t requesting safety and effectiveness data published in the Federal\n\t\t\t Register, publicly available, with redactions for confidential commercial\n\t\t\t information or trade secret information, and any other information exempt\n\t\t\t from disclosure pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ",\n\t\t\t ", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1905", "#text": "section 1905", "@legal-doc": "usc"}, "@value": "usc/18/1905"}, {"#tail": ", or ", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/552", "#text": "section 552(b)", "@legal-doc": "usc"}, "@value": "usc/5/552/b"}, {"#tail": ".", "@entity-type": "act", "#text": "section 301(j) of this\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:j"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Confidentiality of submissions"}, "#text": "\n                ", "@id": "H5657BC4199D94411B0213E0C57CD8560", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Safety and effectiveness data submissions"}, "#text": "\n              ", "@id": "H20C2A0276BB04588BDEFBD24F8238494"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the\n\t\t\t ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": " shall submit the application and the safety and effectiveness\n\t\t\t data submitted under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " to the Nonprescription Drugs Advisory\n\t\t\t Committee (referred to in this section as the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}], "#text": "Not later than 30 days after the end of the public comment period described in ", "quote": {"#tail": ") for review.", "#text": "advisory committee"}}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "New sunscreen condition application submission to the advisory committee"}, "#text": "\n              ", "@id": "H9CDA14BC51044CE8800149B3D78FDF27"}], "#text": "\n            ", "@id": "H332B1070B33042849C91BCA824EF8449"}, {"#tail": "\n          ", "text": {"short-title": [{"#tail": ", the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                "}, {"#tail": ", to be eligible for review of safety and effectiveness and for which the information required\n\t\t\t under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                "}], "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall submit to the advisory committee all safety and effectiveness data submitted\n\t\t\t with respect to each application for review of sunscreen conditions that\n\t\t\t the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " had determined, prior to the date of enactment of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " has been submitted to the ", "@entity-type": "act", "#text": "subsection (f)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": " prior to such\n\t\t\t date of enactment.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#tail": "\n\t\t\t\t\t", "#text": "Not later than 30 days after the date of enactment of the "}, "enum": {"#tail": "\n            ", "#text": "(g)"}, "header": {"#tail": "\n            ", "#text": "Pending sunscreen condition applications"}, "#text": "\n            ", "@id": "H5382F2DE712543B7AB2E06CFD84243E6"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(h)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Review and recommendation for nonprescription sunscreen condition"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall require the advisory committee to evaluate the safety and effectiveness data\n\t\t\t submitted in accordance with ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (f)(2)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:2", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "H9617F4DD2BBF4AA08D2CB04DF3601E83"}, {"#tail": "\n            ", "@id": "H59EE53E5A2F14A9880CABDC9A6B4B6F3", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Standards"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the advisory committee\n\t\t\t shall use the regulations in effect at the time of the application,\n\t\t\t including regulations with respect to\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:1", "@proposed": "true"}, "#text": "In evaluating a nonprescription sunscreen condition under "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the safety of the nonprescription sunscreen condition;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HE5090E4A810E472DBDB9D5B2AF23FAAE", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the effectiveness of the nonprescription sunscreen condition;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HF23EB077694349678F53D641BBDB9C32", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the benefit-to-risk ratio of the nonprescription sunscreen condition; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H86AE734A1F8C4942B0747F946E246861", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the labeling of the nonprescription sunscreen condition."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "HC017E7BD2A814D97AB9FB8D926A469DD", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The advisory committee shall have the authority to communicate with the sponsor and other\n\t\t\t individuals who submit data during the advisory committee's review,\n\t\t\t including requesting clarification or additional information."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Communications between advisory committee and other individuals who submit data"}, "#text": "\n              ", "@id": "H2D2B62BB5756404D84912F05DE20D2B9"}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The sunscreen condition is generally recognized as safe and effective (including any or all\n\t\t\t indications), including nonprescription sunscreen conditions for which a\n\t\t\t new drug application has been approved by the "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HD713DB3AA6E44B6CA61A7B232A2E2504", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Insufficient information has been provided to support a recommendation that the sunscreen condition\n\t\t\t is generally recognized as safe and effective (including any or all\n\t\t\t indications)."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HD03E1FA4435C4AE28726ACD77A9CD61B", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 505(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, "#text": "The sunscreen condition is not generally recognized as safe and effective to be marketed or sold\n\t\t\t unless an application with respect to such condition is approved under\n\t\t\t "}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HEFD25DE178F44A968AA0BADD0025050B", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "subsection (f)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:3", "@proposed": "true"}, {"#tail": ", the advisory committee shall make one of\n\t\t\t the following recommendations to the ", "@entity-type": "act", "#text": "(g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}, {"#tail": ":", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "For each such submission under "}, "#text": "\n                ", "@id": "H0E09A45187C748FEB7F878456F33C847"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " not later than 180 days\n\t\t\t after the advisory committee receives the application and data submitted\n\t\t\t under ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A", "@proposed": "true"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (f)(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:f/p:3", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (g)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:g", "@proposed": "true"}], "#text": "The advisory committee shall make a recommendation under "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Timing"}, "#text": "\n                ", "@id": "H83D6582A4F074B9E836D22F7125B787A", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the advisory committee shall make such\n\t\t\t recommendation not later than 180 days after the date on which such\n\t\t\t additional information is submitted.", "@entity-type": "act", "#text": "subparagraph (A)(ii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:ii", "@proposed": "true"}, "#text": "If the advisory committee recommends that insufficient information has been provided, in accordance\n\t\t\t with "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Resubmission of data"}, "#text": "\n                ", "@id": "H992CC0118F3C419F9DF2CE6AEE593EE0", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Recommendations"}, "#text": "\n              ", "@id": "H91A8A73C183B4277A166667412929C37"}], "#text": "\n            ", "@id": "H2B031DA6CC904392B6D47D8022975A17"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Determination by the Center for Drug Evaluation and Research"}, "paragraph": [{"#tail": "\n            ", "@id": "H40A43702B03D4709858C0AC3DE448E8D", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall respond to the recommendations of the advisory\n\t\t\t committee under ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": " as follows:", "@entity-type": "act", "#text": "subsection (h)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4", "@proposed": "true"}], "#text": "The "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", not later than 45 days after the advisory committee issues the\n\t\t\t recommendation, the ", "@entity-type": "act", "#text": "clause (i) of subsection\n\t\t\t (h)(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:i", "@proposed": "true"}, {"#tail": " shall issue a\n\t\t\t determination affirming or denying the recommendation of the advisory\n\t\t\t committee. If the ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": " affirms the\n\t\t\t recommendation of the advisory committee, or if the ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": " takes no action regarding the recommendation\n\t\t\t within 45 days of receiving such recommendation, the nonprescription\n\t\t\t sunscreen condition shall be generally recognized as safe and effective,\n\t\t\t not misbranded, and permitted to be marketed and sold in accordance with\n\t\t\t all applicable rules and regulations for over-the-counter drugs.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug\n\t\t\t Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "In the case of a recommendation by the advisory committee described in "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H9B67D63D51794EACA697DB6685EC7187", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "clause (ii) of such subsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:ii", "@proposed": "true"}, {"#tail": " shall issue a determination affirming or denying\n\t\t\t the recommendation of the advisory committee, to be made publicly\n\t\t\t available, within 45 days of receiving the recommendation, and inform the\n\t\t\t sponsor that the sponsor must submit additional information to the\n\t\t\t advisory committee in order to continue the review by the advisory\n\t\t\t committee.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug\n\t\t\t Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "In the case of a recommendation described in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HD6FD3606758C44028D737A997C449089", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "clause (iii) of such subsection", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:4/sp:A/cl:iii", "@proposed": "true"}, {"#tail": " shall issue a determination affirming or denying\n\t\t\t the recommendation of the advisory committee, to be made publicly\n\t\t\t available, within 45 days of receiving such recommendation, and indicate\n\t\t\t whether such sunscreen condition determined to be not generally recognized\n\t\t\t as safe and effective to be marketed and sold unless an application with\n\t\t\t respect to such condition is approved under ", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug\n\t\t\t Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}, {"#tail": ", or whether\n\t\t\t additional data must be submitted to the advisory committee.", "@entity-type": "act", "#text": "section 505(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}], "#text": "In the case of a recommendation described in "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "HCBA801C7D00A49759827FEBDFF11E0A3", "#text": "\n                "}]}, {"#tail": "\n          ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to not accept a recommendation of an advisory committee. Such\n\t\t\t review may be conducted at the next supervisory or higher level above the\n\t\t\t individual who made the determination.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation\n\t\t\t and Research", "@value": "Center for Drug Evaluation and Researchf"}, "#text": "Any person may request a supervisory review of a determination of the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "In general"}, "#text": "\n                ", "@id": "H2B73354ABC9942B3BF14C742B348B45E"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be made to the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:h/p:2/sp:A", "@proposed": "true"}, {"#tail": " not later than 30 days after\n\t\t\t such decision and shall indicate in the request whether such person seeks\n\t\t\t an in-person meeting or a teleconference. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall schedule an\n\t\t\t in-person or teleconference review, if so requested, not later than 30\n\t\t\t days after such request is made. The ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " shall issue a decision to\n\t\t\t the person requesting a review under this paragraph not later than 45 days\n\t\t\t after the meeting.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A request described in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Request for supervisory review"}, "#text": "\n                ", "@id": "H1F7DD1930BFB4FCE878FE70323A8A639"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be authorized to overturn a determination of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not to accept a recommendation of the advisory committee if the\n\t\t\t supervisory review results in a decision by the reviewer that the\n\t\t\t individual who made the determination did not provide reasonable and\n\t\t\t sufficient substantive support for the decision to disregard the advisory\n\t\t\t committee's recommendation.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and\n\t\t\t Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Standard of supervisory review"}, "#text": "\n                ", "@id": "HADD50AF911CF484E8A9A759642DE2A39"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " overturns a determination by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " not to\n\t\t\t accept a favorable recommendation of an advisory committee, the\n\t\t\t nonprescription sunscreen condition shall be generally recognized as safe\n\t\t\t and effective, not misbranded, and permitted to be marketed and sold in\n\t\t\t accordance with all applicable rules and regulations for over-the-counter\n\t\t\t drugs.", "@entity-parent-id": "7524", "@entity-type": "federal-body", "#text": "Center for Drug Evaluation and Research", "@value": "Center for Drug Evaluation and Research"}], "#text": "If the "}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "header": {"#tail": "\n                ", "#text": "Supervisory review decision"}, "#text": "\n                ", "@id": "H5F1448C2087D4EDA9330AAABD59F9AD2", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "A decision made through supervisory review shall constitute final agency action subject to judicial\n\t\t\t review."}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "header": {"#tail": "\n                ", "#text": "Final agency action"}, "#text": "\n                ", "@id": "H7B8849A6934F4AD28192EA760944F753", "@commented": "no"}], "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Supervisory review of determination"}, "#text": "\n              ", "@id": "HE6FED2D20F9240BC965BC5491109D83E"}], "#text": "\n            ", "@id": "H5BDBCB398CC24A3C8FF447C987C5CE21"}, {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(j)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Reports"}, "paragraph": [{"#tail": "\n            ", "text": {"short-title": {"#tail": ", on March 1, 2015, and every 2 years thereafter, the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                  "}, "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall issue a report to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t describing actions taken under this section.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#tail": "\n\t\t\t\t\t\t", "#text": "Not later than 1 year after the date of enactment of the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "#text": "\n              ", "@id": "HD2F4D0A9736245039B6FBA79D0C29D0B"}, {"#tail": "\n            ", "@id": "HC2A477C38EEA4C5390EAB89B2DE78180", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Contents"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall include\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:524B/ss:j/p:1", "@proposed": "true"}, "#text": "The reports under "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"short-title": {"#tail": ", including the number of pending applications\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a review of the progress made in issuing in a timely manner decisions on the safety and\n\t\t\t effectiveness for sunscreen conditions for applications pending as of the\n\t\t\t date of enactment of the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "reviewed and the decision times for each application, measured from the date of original\n\t\t\t eligibility application submission by the sponsor;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HE7C6C2F609FF4406A48C288B745ED44C", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "resulting in a determination of generally recognized as safe and effective and not misbranded;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HBD9A790AE74845AB843513EF9D642B7F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "resulting in a determination of not generally recognized as safe and effective and not misbranded\n\t\t\t and the reasons for such determinations; and"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "H762175DE444245E19B75A7B25EFEF9B0", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "for which a determination has not been made, an explanation for the delay, a description of the\n\t\t\t current status of each such application, and the length of time such\n\t\t\t applications have been pending, measured from the date of original\n\t\t\t eligibility application submission by the sponsor;"}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "H57807CFDD9A74A19B61866E76A4DDA79", "#text": "\n                  "}], "#text": "\n                ", "@id": "H84BDE97090DB4784B5322D1E27BF13BD"}, {"#tail": "\n              ", "text": {"short-title": {"#tail": ", including the number of such applications\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "act", "#text": "Sunscreen Innovation Act", "@value": "Sunscreen Innovation Act", "@proposed": "true"}, "#text": "\n                    "}, "#tail": "\n\t\t\t\t\t\t\t\t", "#text": "a review of the progress made in issuing in a timely manner a decision on safety and effectiveness\n\t\t\t for sunscreen condition applications submitted after the date of enactment\n\t\t\t of the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "reviewed and the decision times for each application;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H10774E92560842CFB903F9A2D3008156", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "resulting in a determination of generally recognized as safe and effective and not misbranded; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H4A2EBC88268941E7B1B51D1ED0B30D3A", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "resulting in a determination of not generally recognized as safe and effective and not misbranded\n\t\t\t and the reasons for such determinations;"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "H00AD647E1182426593A92C3BC03B2EDF", "#text": "\n                  "}], "#text": "\n                ", "@id": "H4AD88DCF1C5F44C38D42D38F41C4FDF5"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a description of the staffing and resources relating to the costs associated with the review and\n\t\t\t decisionmaking pertaining to applications;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H738C798FD7DC43939EAA09F6B1F1E125", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a review of the progress in meeting the deadlines with respect to processing applications under\n\t\t\t this section;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "H888D3C7BF69E4F3A9E4486AE68A4CA28", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determines appropriate, recommendations for process improvements in the\n\t\t\t handling of pending and new applications; and", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "to the extent the "}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "H4C6932C331E04171B7F528622DFE7D08", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "recommendations for expanding the applicability of this section to nonprescription active\n\t\t\t ingredients or conditions that are not related to the sunscreen category\n\t\t\t of over-the-counter drugs."}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "HFA512390E4534091AF2340D002AEE212", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall publish the reports required under this subsection in the manner the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n\t\t\t determines to be the most effective for efficiently disseminating the\n\t\t\t report, including publication of the report on the Internet website of the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Method"}, "#text": "\n              ", "@id": "H28ADCBB1C5EB41EA9D91067E64F1664E"}], "#text": "\n            ", "@id": "HB982DE22153C4929B217787B55BD945D"}, {"#tail": "\n        ", "enum": {"#tail": "\n            ", "#text": "(k)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Rules of construction"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " authority to withdraw or\n\t\t\t suspend from the market a drug that the ", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}, {"#tail": " determines to be unsafe\n\t\t\t or ineffective.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Nothing in this section shall be construed to alter the "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Authority to withdraw or suspend"}, "#text": "\n              ", "@id": "HF73B3509170C4FB081980FEA64791F42"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " authority to review nonprescription conditions\n\t\t\t other than sunscreen conditions.", "@entity-type": "federal-body", "#text": "Secretary's", "@entity-id": "7500"}, "#text": "Nothing in the section shall affect the "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Other conditions"}, "#text": "\n              ", "@id": "H4D992ADEBBA34308855AED85E4135918"}], "#text": "\n            ", "@id": "HFFCEF8D5474D436EB0F46868F3BE108F"}], "#text": "\n          ", "@id": "H93650B9566274A268282FA071411CF0D"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "H2688DD524DFF47A98804B1A584474E29"}, "#text": "\n      ", "@id": "HC746E5539E9841F69275E65CA66B1B31"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall issue\n\t\t\t determinations with respect to\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Not later than 180 days after the date of enactment of this Act, the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Sunscreen testing and labeling"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "the appropriate testing and labeling requirements for sunscreens sold as an aerosol; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H9AEFC64E9D7F422A87F5781EB2A65B26", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "whether sunscreen may contain a label indicating a sun protection factor greater than 50.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "H27D12993EF6D4BA482C24B6A15218499", "#text": "\n        "}], "#text": "\n      ", "@id": "H00C2BB6F2245457D97DEE6800B669968"}], "#text": "\n\t\t", "@id": "H73122D2FA0EA49379368B76998F88E88"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-03-13"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4250 IH: Sunscreen Innovation Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}